Cellectar Biosciences, Inc. Quarterly Return On Assets in % from Q1 2012 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cellectar Biosciences, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q1 2024.
  • Cellectar Biosciences, Inc. Return On Assets for the quarter ending March 31, 2024 was -246 %, a 61.5% decline year-over-year.
  • Cellectar Biosciences, Inc. annual Return On Assets for 2023 was -276 %, a 139% decline from 2022.
  • Cellectar Biosciences, Inc. annual Return On Assets for 2022 was -116 %, a 118% decline from 2021.
  • Cellectar Biosciences, Inc. annual Return On Assets for 2021 was -53 %, a 1.72% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -246 -93.5 -61.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -276 -161 -139% Oct 1, 2023 Dec 31, 2023
Q3 2023 -234 -139 -145% Jul 1, 2023 Sep 30, 2023
Q2 2023 -205 -131 -177% Apr 1, 2023 Jun 30, 2023
Q1 2023 -152 -91.9 -153% Jan 1, 2023 Mar 31, 2023
Q4 2022 -116 -62.8 -118% Oct 1, 2022 Dec 31, 2022
Q3 2022 -95.5 -52.6 -123% Jul 1, 2022 Sep 30, 2022
Q2 2022 -73.9 -30.2 -69% Apr 1, 2022 Jun 30, 2022
Q1 2022 -60.2 -16 -36.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -53 +0.93 +1.72% Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.9 +47.9 +52.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -43.7 +54.6 +55.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -44.2 +59.3 +57.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -54 +40.6 +43% Oct 1, 2020 Dec 31, 2020
Q3 2020 -90.8 +2.46 +2.64% Jul 1, 2020 Sep 30, 2020
Q2 2020 -98.3 -15.9 -19.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -104 -4.66 -4.71% Jan 1, 2020 Mar 31, 2020
Q4 2019 -94.6 +8.93 +8.63% Oct 1, 2019 Dec 31, 2019
Q3 2019 -93.2 +17 +15.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -82.4 +59.6 +42% Apr 1, 2019 Jun 30, 2019
Q1 2019 -98.9 +27.1 +21.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -104 +3.6 +3.36% Oct 1, 2018 Dec 31, 2018
Q3 2018 -110 -19.3 -21.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -142 -59 -71.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -126 -48.8 -63.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -107 -47.7 -80.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -90.9 -59.7 -191% Jul 1, 2017 Sep 30, 2017
Q2 2017 -82.9 -54.3 -190% Apr 1, 2017 Jun 30, 2017
Q1 2017 -77.2 -43.6 -130% Jan 1, 2017 Mar 31, 2017
Q4 2016 -59.5 +6.04 +9.22% Oct 1, 2016 Dec 31, 2016
Q3 2016 -31.3 +68.2 +68.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -28.6 +34 +54.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -33.6 +30.9 +47.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -65.5 +9.27 +12.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -99.5 -4.56 -4.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -62.6 +72.9 +53.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -64.5 +47.7 +42.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -74.8 +25.8 +25.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -94.9 -19.3 -25.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -135 -54.9 -68.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -112 -29.8 -36.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -101 -17.5 -21% Oct 1, 2013 Dec 31, 2013
Q3 2013 -75.6 +7.43 +8.95% Jul 1, 2013 Sep 30, 2013
Q2 2013 -80.6 +8.39 +9.43% Apr 1, 2013 Jun 30, 2013
Q1 2013 -82.4 +19.5 +19.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -83.1 Oct 1, 2012 Dec 31, 2012
Q3 2012 -83.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -89 Apr 1, 2012 Jun 30, 2012
Q1 2012 -102 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.